Table 2.

Relative incidence of intussusception in the 1–7, 8–21 and 1–21 day risk windows following the first and second doses of rotavirus vaccine in Afghanistan, Myanmar and Pakistan and in Afghanistan and Pakistan.

	All		Afghanistan and Pakistan only
Dose and risk window	No. of cases	Relative incidence (95%CI)	No. of cases	Relative incidence (95%CI)
Dose 1
1–7 days	5	1.01 (0.39, 2.60)	5	1.08 (0.42, 2.80)
8–21 days	19	1.37 (0.81, 2.32)	14	1.04 (0.57, 1.88)
1–21 days	24	1.28 (0.78, 2.11)	19	0.97 (0.56, 1.69)
Dose 2
1–7 days	10	0.81 (0.42, 1.54)	9	0.76 (0.38, 1.51)
8–21 days	23	0.77 (0.49, 1.21)	18	0.64 (0.39, 1.05)
1–21 days	33	0.78 (0.53, 1.16)	27	0.63 (0.41, 0.97)